Send to printer »

GEN News Highlights : Mar 4, 2009

Nanogen Licenses Technology to Quest for In Vitro Diagnostic Testing

Quest Diagnostics obtained rights to use and sell products and services incorporating Nanogen’s MGB (minor groove binder) Probe technology. According to the end-user license agreement, Quest will pay an up-front fee and royalties on tests sold using this technology. Quest will be able to use this platform in human in vitro diagnostic testing.